<DOC>
	<DOCNO>NCT00790582</DOCNO>
	<brief_summary>This Phase II screen study lithium carbonate ALS . The purpose study find lithium carbonate safe used people ALS slow progression disease . Since placebo study , patient take lithium carbonate .</brief_summary>
	<brief_title>A Multi-Center Controlled Screening Trial Safety Efficacy Lithium Carbonate Subjects With Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>This Phase II Screening study . There placebo ( inactive 'fake ' drug ) study , mean participant take lithium carbonate . The purpose study find lithium carbonate safe used people ALS slow progression disease . A recent article publish highly regarded medical journal show positive effect lithium carbonate ALS type mouse . The researcher study small number people ALS , give 16 people lithium carbonate riluzole give 28 people riluzole . The people take lithium remain strong considerably longer period time . However , study small really tell lithium work unless large study perform . It well understood lithium carbonate might helpful believe may play role protect motor nerve damage ALS . If choose participate , need go study clinic research study visit 7 time one year 4 telephone interview time . These visit phone call could take 17 hour total . Caution : Lithium FDA approve drug use psychiatric disorder . It FDA approve ALS . Lithium many potentially serious side effect must take close supervision physician .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Clinical diagnosis laboratorysupported probable , probable , definite ALS Vital capacity least 75 % predict Onset weakness within 3 year prior enrollment If patient riluzole , must stable dose least 30 day prior baseline visit Women childbearing potential must surgically sterile use effective method birth control negative pregnancy test Willing able give inform consent Diagnosis neurodegenerative disease Need tracheotomy ventilation noninvasive ventilation 23 hours/day Clinically significant history unstable medical condition past 30 day History renal History liver disease Current pregnancy lactation Use lithium within thirty day enrollment Significantly limited mental capacity History recent drug alcohol abuse Use investigational drug within 30 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>ALS</keyword>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Lou Gehrig 's Disease</keyword>
	<keyword>Lithium</keyword>
	<keyword>Lithium Carbonate</keyword>
</DOC>